Table 3 Multivariable Cox regression analysis for mortality.

From: Effect of early prophylactic heparin use on prognosis in critically ill patients with acute pancreatitis: a retrospective cohort study

Outcome

Model I

Model II

Model III

HR (95% CI)

P-value

HR (95% CI)

P-value

HR (95% CI)

P-value

28-day mortality

      

 Original cohort

0.62 (0.42–0.90)

0.022

0.59 (0.40–0.86)

0.006

0.62 (0.41–0.95)

0.027

 Matched cohort

0.61 (0.37–0.99)

0.044

0.58 (0.35–0.94)

0.026

0.55 (0.31–0.95)

0.031

180-day mortality

      

 Original cohort

0.64 (0.48–0.85)

0.002

0.61 (0.46–0.82)

< 0.001

0.65 (0.48–0.90)

0.008

 Matched cohort

0.62 (0.44–0.89)

0.009

0.59 (0.42–0.84)

0.004

0.56 (0.38–0.85)

0.006

In-hospital mortality

      

 Original cohort

0.60 (0.41–0.88)

0.009

0.57 (0.39–0.83)

0.004

0.60 (0.39–0.92)

0.018

 Matched cohort

0.59 (0.36–0.96)

0.034

0.55 (0.34–0.90)

0.018

0.54 (0.30–0.96)

0.036

  1. Model I: crude.
  2. Model II: adjusted for age, gender, ethnicity, weight.
  3. Model III: adjusted for model II, covariates, ventilation, CRRT, vasopressin, malignancy, renal failure, heart failure, platelets, WBC, RBC, AG, BUN, creatinine, INR, MAP, respirator rate, temperature, SOFA, SAPS II, CCI.